Literature DB >> 11287562

Sequences in the cytoplasmic tail of the gibbon ape leukemia virus envelope protein that prevent its incorporation into lentivirus vectors.

I Christodoulopoulos1, P M Cannon.   

Abstract

Pseudotyping retrovirus and lentivirus vectors with different viral fusion proteins is a useful strategy to alter the host range of the vectors. Although lentivirus vectors are efficiently pseudotyped by Env proteins from several different subtypes of murine leukemia virus (MuLV), the related protein from gibbon ape leukemia virus (GaLV) does not form functional pseudotypes. We have determined that this arises because of an inability of GaLV Env to be incorporated into lentivirus vector particles. By exploiting the homology between the GaLV and MuLV Env proteins, we have mapped the determinants of incompatibility in the GaLV Env. Three modifications that allowed GaLV Env to pseudotype human immunodeficiency virus type 1 particles were identified: removal of the R peptide (C-terminal half of the cytoplasmic domain), replacement of the whole cytoplasmic tail with the corresponding MuLV region, and mutation of two residues upstream of the R peptide cleavage site. In addition, we have previously proposed that removal of the R peptide from MuLV Env proteins enhances their fusogenicity by transmitting a conformational change to the ectodomain of the protein (Y. Zhao et al., J. Virol. 72:5392-5398, 1998). Our analysis of chimeric MuLV/GaLV Env proteins provides further evidence in support of this model and suggests that proper Env function involves both interactions within the cytoplasmic tail and more long-range interactions between the cytoplasmic tail, the membrane-spanning region, and the ectodomain of the protein.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11287562      PMCID: PMC114158          DOI: 10.1128/JVI.75.9.4129-4138.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  66 in total

1.  Mutational analysis of the envelope gene of Moloney murine leukemia virus.

Authors:  K D Gray; M J Roth
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

2.  Retrovirus packaging cells based on 10A1 murine leukemia virus for production of vectors that use multiple receptors for cell entry.

Authors:  A D Miller; F Chen
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

3.  Effect of retroviral proteinase inhibitors on Mason-Pfizer monkey virus maturation and transmembrane glycoprotein cleavage.

Authors:  M A Sommerfelt; S R Petteway; G B Dreyer; E Hunter
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

4.  Improved gene transfer into human lymphocytes using retroviruses with the gibbon ape leukemia virus envelope.

Authors:  J S Lam; M E Reeves; R Cowherd; S A Rosenberg; P Hwu
Journal:  Hum Gene Ther       Date:  1996-08-01       Impact factor: 5.695

5.  Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells.

Authors:  J C Burns; T Friedmann; W Driever; M Burrascano; J K Yee
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

6.  pH-independent murine leukemia virus ecotropic envelope-mediated cell fusion: implications for the role of the R peptide and p12E TM in viral entry.

Authors:  J A Ragheb; W F Anderson
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

7.  Receptor-binding domain of murine leukemia virus envelope glycoproteins.

Authors:  J L Battini; O Danos; J M Heard
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

8.  Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein.

Authors:  A Rein; J Mirro; J G Haynes; S M Ernst; K Nagashima
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

9.  Increased gene transfer into human hematopoietic progenitor cells by extended in vitro exposure to a pseudotyped retroviral vector.

Authors:  C von Kalle; H P Kiem; S Goehle; B Darovsky; S Heimfeld; B Torok-Storb; R Storb; F G Schuening
Journal:  Blood       Date:  1994-11-01       Impact factor: 22.113

10.  Hemagglutinin activation of pathogenic avian influenza viruses of serotype H7 requires the protease recognition motif R-X-K/R-R.

Authors:  M Vey; M Orlich; S Adler; H D Klenk; R Rott; W Garten
Journal:  Virology       Date:  1992-05       Impact factor: 3.616

View more
  44 in total

1.  Transduction efficiency of MLV but not of HIV-1 vectors is pseudotype dependent on human primary T lymphocytes.

Authors:  Michael D Mühlebach; Isabel Schmitt; Stefanie Steidl; Jörn Stitz; Matthias Schweizer; Thomas Blankenstein; Klaus Cichutek; Wolfgang Uckert
Journal:  J Mol Med (Berl)       Date:  2003-10-24       Impact factor: 4.599

2.  Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses.

Authors:  Virginie Sandrin; Delphine Muriaux; Jean-Luc Darlix; François-Loïc Cosset
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

3.  Targeted entry via somatostatin receptors using a novel modified retrovirus glycoprotein that delivers genes at levels comparable to those of wild-type viral glycoproteins.

Authors:  Fang Li; Byoung Y Ryu; Robin L Krueger; Scott A Heldt; Lorraine M Albritton
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

4.  Characterization of retroviral and lentiviral vectors pseudotyped with xenotropic murine leukemia virus-related virus envelope glycoprotein.

Authors:  Toshie Sakuma; Suk See De Ravin; Jason M Tonne; Tayaramma Thatava; Seiga Ohmine; Yasuhiro Takeuchi; Harry L Malech; Yasuhiro Ikeda
Journal:  Hum Gene Ther       Date:  2010-09-17       Impact factor: 5.695

Review 5.  Altering the tropism of lentiviral vectors through pseudotyping.

Authors:  James Cronin; Xian-Yang Zhang; Jakob Reiser
Journal:  Curr Gene Ther       Date:  2005-08       Impact factor: 4.391

6.  Directed evolution of retrovirus envelope protein cytoplasmic tails guided by functional incorporation into lentivirus particles.

Authors:  Christoph A Merten; Jörn Stitz; Gundula Braun; Eric M Poeschla; Klaus Cichutek; Christian J Buchholz
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

7.  Foreign glycoproteins can be actively recruited to virus assembly sites during pseudotyping.

Authors:  Rebecca L Jorgenson; Volker M Vogt; Marc C Johnson
Journal:  J Virol       Date:  2009-02-18       Impact factor: 5.103

8.  Targeted cell entry of lentiviral vectors.

Authors:  Sabrina Funke; Andrea Maisner; Michael D Mühlebach; Ulrike Koehl; Manuel Grez; Roberto Cattaneo; Klaus Cichutek; Christian J Buchholz
Journal:  Mol Ther       Date:  2008-06-24       Impact factor: 11.454

9.  Functional role of the cytoplasmic tail domain of the major envelope fusion protein of group II baculoviruses.

Authors:  Gang Long; Xiaoyu Pan; Marcel Westenberg; Just M Vlak
Journal:  J Virol       Date:  2006-11       Impact factor: 5.103

Review 10.  Library screening and receptor-directed targeting of gammaretroviral vectors.

Authors:  Peter M Mazari; Monica J Roth
Journal:  Future Microbiol       Date:  2013-01       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.